Table 3 Comparison of the diagnosis and treatment measures between the two groups of patients.
From: In-hospital recurrence in a Chinese large cohort with acute ischemic stroke
Total N = 1021 | Recurrence N = 58 | Non-recurrence N = 963 | P value | |
|---|---|---|---|---|
Head CT (%) | 855 (83.74) | 52 (89.66%) | 803 (83.39%) | 0.209 |
Head MRI (%) | 979 (95.89%) | 55 (94.83%) | 924 (95.95%) | 0.676 |
Head MRA, CTA, DSA (%) | 907 (88.83%) | 50 (86.21%) | 857 (88.99%) | 0.513 |
Cervical vascular ultrasound (%) | 938 (91.87%) | 55 (94.83%) | 882 (91.59%) | 0.179 |
Echocardiography (%) | 952 (93.24%) | 54 (93.10%) | 898 (93.25%) | 0.965 |
Dynamic electrocardiogram (%) | 81 (7.93%) | 4 (6.90%) | 77 (8.00%) | 0.764 |
Intravenous thrombolysis (%) | 92 (9.01%) | 4 (6.90%) | 88 (9.14%) | 0.812 |
Antiplatelet (%) | 984 (96.38%) | 55 (94.83%) | 929 (96.47%) | 0.462 |
Anticoagulant (%) | 35 (3.43%) | 4 (6.90%) | 31 (3.22%) | 0.132 |
Antihypertensive drug (%) | 492 (48.19%) | 27 (46.55%) | 465 (48.29%) | 0.797 |
Blood glucose reduction (%) | 288 (28.21%) | 21 (36.21%) | 267 (27.73%) | 0.163 |
Statins (%) | 933 (91.38%) | 55 (94.83%) | 878 (85.99%) | 0.336 |
Endovascular treatment | 7 (0.69%) | 2 (3.44%) | 5 (0.52%) | 0.055 |
